Depressive Disorders - Worldwide | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$22.61bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.83%, resulting in a market volume of US$23.56bn by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$64.96 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Worldwide is experiencing significant growth and development.

Customer preferences: Customers in the Depressive Disorders market are increasingly seeking out more accessible and convenient treatment options. This has led to a rise in the demand for telemedicine services, online therapy platforms, and mobile applications that provide mental health support. Additionally, there is a growing preference for personalized treatment plans that take into account individual needs and circumstances.

Trends in the market: One major trend in the Depressive Disorders market is the increasing awareness and destigmatization of mental health issues. This has resulted in more individuals seeking help for their depressive symptoms, leading to a larger customer base for treatment providers. In addition, there is a growing emphasis on holistic approaches to treatment, which incorporate not only medication but also therapy, lifestyle changes, and self-care practices. Another trend is the integration of technology into the treatment of depressive disorders. This includes the use of artificial intelligence and machine learning algorithms to develop more accurate diagnostic tools and personalized treatment plans. Additionally, virtual reality therapy is emerging as a promising treatment option, providing patients with immersive and interactive experiences to help them manage their depressive symptoms.

Local special circumstances: In some countries, there are specific cultural factors that influence the prevalence and treatment of depressive disorders. For example, in certain Asian countries, there is a higher stigma associated with mental health issues, which can deter individuals from seeking treatment. In these regions, there is a need for targeted awareness campaigns and education to reduce the stigma and encourage help-seeking behaviors.

Underlying macroeconomic factors: The global rise in mental health disorders, including depressive disorders, can be attributed to various macroeconomic factors. These include increasing urbanization, changing lifestyles, and the impact of social media and technology on mental well-being. Additionally, the COVID-19 pandemic has had a significant impact on mental health worldwide, with increased rates of depression and anxiety. The economic consequences of the pandemic, such as job loss and financial instability, have further exacerbated the prevalence of depressive disorders. In conclusion, the Depressive Disorders market in Worldwide is experiencing growth and development driven by customer preferences for accessible and personalized treatment options. The market is also influenced by trends such as the destigmatization of mental health issues and the integration of technology into treatment. Local special circumstances, such as cultural factors, can impact the market dynamics in specific regions. Additionally, macroeconomic factors, including urbanization and the impact of the COVID-19 pandemic, play a significant role in the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.